OverviewSuggest Edit

stimOS is a company that develops a patented mimicking bone technology created to transform implant surfaces from an artificial barrier into a bone identical implant body interface. Its mimicking bone technology is a biochemical procedure that initiates early and healthy bone formation, anti-inflammatory activity, and fast healing process, enabling patients to get required possible recovery and achieve a pain-free life after surgery.

Latest Updates

Employees (est.) (Jul 2021)4
Cybersecurity ratingAMore

stimOS Financials and Metrics

Summary Metrics

Founding Date


stimOS total Funding

$839.5 k

Time since last funding

a year ago

stimOS investors

Show all financial metrics

stimOS Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

stimOS Online and Social Media Presence

Embed Graph

stimOS News and Updates

stimOS Raises Series A Funding Round

stimOS GmbH, a Constance, Germany-based medical technology company, raised a a Series A funding round of undisclosed amount. WEFA Inotec GmbH, a German market leader in extrusion tooling, precision technology and CVD coatings, participated in the round, along with HTGF, MBG and founding partner Diet…

stimOS Frequently Asked Questions

  • When was stimOS founded?

    stimOS was founded in 2015.

  • How many employees does stimOS have?

    stimOS has 4 employees.

  • Who are stimOS competitors?

    Competitors of stimOS include Care & Planning for Hospitals, Keranova and SentreHEART.